Gemcitabine and the monoclonal antibody nimotuzumab versus gemcitabine and placebo for the treatment of chemotherapy-naive patients (pts) with advanced pancreatic cancer (PC): A multicentre, randomized phase IIb/IIIa study için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Gemcitabine and the monoclonal antibody nimotuzumab versus gemcitabine and placebo for the treatment of chemotherapy-naive patients (pts) with advanced pancreatic cancer (PC): A multicentre, randomized phase IIb/IIIa study | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Kasım 2024 | 0 |
| Aralık 2024 | 0 |
| Ocak 2025 | 0 |
| Şubat 2025 | 0 |
| Mart 2025 | 0 |
| Nisan 2025 | 0 |
| Mayıs 2025 | 0 |
